Jade Biosciences JBIO
NASDAQ JBIO
$14.91 -0.22 (-1.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Net Debt Issuances and Repayments (2024)

Updated

Analysis

Jade Biosciences (JBIO) Net Debt Issuances and Repayments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -4.36 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -2.00 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -2.46 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 64.00 Mn
10 Jade Biosciences 903.31 Mn -404.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 95.00 Mn
API Access

Jade Biosciences Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=JBIO&period=max&api_key=YOUR_API_KEY